Funding for Cancer Research Trainees

Additional Details

RFP Snapshot: The AACR offers Scholar-in-Training Awards to enhance the education and training of early career scientists by providing financial support for their attendance at AACR conferences and meetings. The number of awards available, award amounts, and application requirements vary by conference. Please visit the meetings and workshops calendar for a list of upcoming programs and details on financial support available.

Eligibility: Applicants who submit abstracts must be AACR members in good standing. Nonmembers should submit a Membership Application Form.

Rolling Due Dates

Additional Details

RFP Snapshot: This is a year-long training and mentoring experience. It begins with a week-long course held in the March of 2024 in France. The focus of the TRTH program is on laboratory-based translational research in hematology fields. Research projects must be hypothesis-driven and directly connected to some aspects of human biology. Projects may encompass any form of cellular, molecular, structural, biochemical, genetic, or other appropriate experimental approach using human biological material or human subjects with the aim of reaching novel insights into human biology. Pilot and early phase clinical studies translating the laboratory discoveries “to the bedside” may be included in the proposal, however, pure clinical trial projects with laboratory correlatives will not be considered.

Max Amount and Period: Travel expenses (economy class airfare/train, accommodation, and meals) during the Spring Course and follow up meetings are arranged and covered by the program.

Eligibility: Applicants must be a trainee or junior faculty member with a MD and/or PhD OR a biomedical PhD OR a PharmD degree in basic and translational research in classical or malignant hematology. Applicants must be actively employees in a hematology or hematology-related research environment. Both the applicant and the applicant’s mentor should either be an EHA member or ASH member at the time of submission. Applicants who have obtained funding indicative of independent research status are NOT eligible to apply.

Due Date: Letter of Intent Due: June 15, 2023

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: These grants, which will provide support to postdoctoral or clinical research fellows who are females or are from underrepresented groups (please see eligibility criteria below), combine research experiences in both academic and industry settings, following a research timeline that will be of greatest benefit to the proposed work. Research proposals may be basic, translational, or clinical in nature, but must have direct applicability to lung cancer. Proposals focused on mechanisms linking immunogenic cell death pathways to amplification of innate and adaptive immunity, immunobiology of non-small cell lung cancers, and mechanisms of acquired resistance to immunotherapies are highly encouraged.

Max Amount and Period: $225,000 over 3 years

Eligibility: Applicants must be female OR belong to one of the following underrepresented groups as per NIH guidelines: a) individuals from racial and ethnic groups that have been shown to be underrepresented in health-related sciences, b) individuals with disabilities, c) or individuals from disadvantaged backgrounds. Applicants must have a doctoral degree (PhD, MD, MD/PhD) in a related field and not currently be a candidate for a further doctoral degree. Applicants must hold a full-time, mentored research position with the title of postdoctoral fellow, clinical research fellow, or equivalent. Must have begun their postdoctoral fellowship training within the past three (3) years.

Due Date: June 21, 2023 at Noon CST

Application Assistance: Washington University faculty may also reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Multiple Myeloma Research Foundation (MMRF) seeks proposals for the MMRF 2023 Research Fellowship Program, an initiative supporting early career researchers at the post-doctorate, medical fellow, or junior faculty levels currently active or interested in research in multiple myeloma. The goal of this initiative is to engage and support early career investigators interested in basic and clinical research focused on multiple myeloma and its precursor conditions, with the goal of advancing our understanding of myeloma disease biology, disease risk, and treatment response and relapse.

Max Amount and Period: $150,000 over 2 years

Eligibility: Researchers with a PhD, MD, or equivalent degree at the post-doctorate, clinical fellow, or junior faculty level are encouraged to apply. Applicants need not be US citizens. The following conditions must be met by all applicants:

• Post-doctorate and medical fellows applying for the award must work under the supervision of a research mentor in the multiple myeloma field
• Applicants must have obtained their highest degree within 10 years of the application date.
• Applicants may not hold a position higher than Assistant Professor.
• Applicants who are beginning studies in the multiple myeloma field must have a research sponsor/mentor at their institution who is active in the multiple myeloma field, and who can provide guidance to the applicant in the proposed area of research.

Due Date: June 23, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: SCC is excited to offer an Edward P. Evans Postdoctoral Position for Myelodysplastic Syndromes (MDS) research. Interested postdocs should complete the Cancer Biology Pathway application, indicate their interest, and describe their MDS research project. Please note: the MDS position covers $26,800 in stipend support for one year. Any support beyond that amount must be supplemented by the mentor, department, or through another award.

Max Amount and Period: $26,800 for 1 year

Eligibility: Applicants must have a PhD, MD, or MD/PhD degree and may be on a temporary US visa. They may propose to participate in the program for one year or two years and are allowed to have supplemental funding while appointed to the program.

Due Date: June 30, 2023 at 10:59PM CST

July Deadlines

Additional Details

RFP Snapshot: The Pablove Foundation invests in underfunded, cutting-edge pediatric cancer research and improves the lives of children living with cancer through the arts. Our mission is built on our impassioned desire to know more, find better, less toxic treatments, and a cure, and to allow kids living with cancer to still be kids while undergoing treatment. Funding priority is for research in less common childhood cancers. Proposed research can be in the following areas: mechanisms of disease, genetics, preclinical models, biomarkers and surrogate markers, prognostic factors, treatment, etc.

Max Amount and Period: $50,000 for 1 year

Eligibility: All Powered by Pablove Seed Grants are designed for researchers currently towards the end of their clinical fellowship or postdoctoral training or within five (5) years of completion of training. Applicants must have an MD or PhD or equivalent degree. International applicants and institutions are welcome to apply for all grants; there is no residency requirement. Past Powered by Pablove grant recipients are not eligible to apply.

Due Date: July 6, 2023 at 4PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Damon Runyon Fellowship identifies the nation’s top postdoctoral fellows and provides funding that enables them to complete their training under the mentorship of a leading senior scientist and encourages them to follow their own bold ideas. At the end of the Fellowship, there are often a select few who have greatly exceeded the Foundation’s highest expectations. These spectacular young scientists are the most likely to make paradigm-shifting breakthroughs that transform the way we prevent, diagnose and treat cancer. To catapult their research careers—and their impact on cancer—the Foundation will make an additional investment in these exceptional individuals by selecting them as recipients of the Damon Runyon-Dale F. Frey Award for Breakthrough Scientists.

Max Amount and Period: $100,000 for 1 year

Eligibility: Damon Runyon Fellows are eligible to apply in the final year of their Fellowship. Currently, Damon Runyon Fellows selected in November 2019, May 2020, and February 2021 (DRG-2385-20 to DRG-2417-20, DRSG-32-20 to DRSG-33-20, DRQ-10-21 to DRQ-12-21) are eligible to apply.

Due Date: July 14, 2023 at 3PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at floydg@wustl.edu with any questions and for assistance with reviewing/editing your proposal.